Fangyuan Chen

Fangyuan Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fangyuan Chen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Ailing Su

    Biobank, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China

    1 shared publication
  • Bianbian Wang

    Center for Mitochondrial Biology and Medicine, School of Life Science and Technology, and

    1 shared publication
  • Bin Zhou

    CAS CEMCS-CUHK Joint Laboratory, New Cornerstone Science Laboratory, Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China

    1 shared publication
  • Changhe Wang

    Neuroscience Research Center, Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an, China

    1 shared publication
  • Guozheng Liang

    Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany

    1 shared publication
  • Huijing Tian

    Department of Cardiac Surgery, the First Affiliated Hospital of Xi’an Jiaotong University, Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    PIEZO1 mediates periostin+ myofibroblast activation and pulmonary fibrosis in mice

    by Liran Xu, Ting Li, Yapeng Cao, Yu He, Zehua Shao, Siyu Liu, Bianbian Wang, Ailing Su, Huijing Tian, Yongxin Li, et al.

    Idiopathic pulmonary fibrosis (IPF) is a devastating interstitial lung disease characterized by the excessive accumulation of activated myofibroblasts that deposit extracellular matrix (ECM) protein, leading to progressive scar formation and mechanical stress. However, the cellular origin and fate of myofibroblasts remain controversial, and the mechanisms by which myofibroblasts sense mechanical cues in the lung are unclear. Here, we report that periostin (Postn) is a reliable and distinctive marker for pulmonary myofibroblasts, while ablation of Postn + myofibroblasts after injury ameliorated lung fibrosis. PIEZO1 was highly expressed in Postn + myofibroblast and played a vital role in mechanoactivation of Postn + myofibroblast and development of lung fibrosis. Conditional deletion of Piezo1 in Postn + myofibroblasts significantly inhibited lung fibrosis by suppressing myofibroblast activation and proliferation. Loss of Piezo1 led to disruption of actin organization and prevention of Yap/Taz nuclear localization, thus shifting the myofibroblasts from a proliferative state into a stressed and apoptotic state. Furthermore, myofibroblast-specific Yap/Taz deletion fully recapitulated the protective phenotypes of myofibroblast- Piezo1 –KO mice. These findings show that periostin marks pulmonary myofibroblasts, and that PIEZO1-mediated mechanosensation is essential for myofibroblast activation in the lung. Targeting PIEZO1 in the periostin-expressing cells is a novel therapeutic option to interfere with fibrotic diseases such as IPF .